<style>
td{
	vertical-align:top;
	border-style: solid;
	border-width: 1px;
	border-collapse: collapse;
}
th{
	background-color:lightgray;
}
</style>
<p>Included trials, starting with the oldest trials.</p>
<table>
<caption>Randomized controlled trials of this topic</caption>
<tbody><tr>
<th>
Trial
</th>
<th>
Patients
</th>
<th>
Intervention
</th>
<th>
Comparison
</th>
<th>
Outcome
</th>
</tr>
<tr>
<td>
Sarrell, 2002<br>Chest<br> PMID: <a href="http://pubmed.gov/12475841" target="_blank">12475841</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Mandelberg, 2003<br>Chest<br> PMID: <a href="http://pubmed.gov/12576370" target="_blank">12576370</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Tai, 2006<br>Isr Med Assoc J<br> PMID: <a href="http://pubmed.gov/16599051" target="_blank">16599051</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Kuzik, 2007<br>J Pediatr<br> PMID: <a href="http://pubmed.gov/17719935" target="_blank">17719935</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Anil, 2009<br>J Pediatr Pulmonol<br> PMID: <a href="http://pubmed.gov/19953579" target="_blank">19953579</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Grewal, 2009<br>J Arch Pediatr Adolesc Med<br> PMID: <a href="http://pubmed.gov/19884591" target="_blank">19884591</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
El Ansari, 2010<br>J Pediatr<br> PMID: <a href="http://pubmed.gov/20646715" target="_blank">20646715</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Luo, 2010<br>Pediatr Int<br> PMID: <a href="http://pubmed.gov/19674354" target="_blank">19674354</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Luo, 2011<br>Clin Microbiol Infect<br> PMID: <a href="http://pubmed.gov/20636429" target="_blank">20636429</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Ipek, 2011<br>Pulm Pharmacol Ther<br> PMID: <a href="http://pubmed.gov/20636429" target="_blank">21978929</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Miraglia Del Giudice, 2012<br>Int J Immunopathol Pharmacol<br> PMID: <a href="http://pubmed.gov/22697080" target="_blank">22697080</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Sharma, 2013<br>Indian Pediatr<br> PMID: <a href="http://pubmed.gov/23502662" target="_blank">23502662</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Jacobs, 2014<br>Pediatrics<br> PMID: <a href="http://pubmed.gov/24344111" target="_blank">24344111</a>
</td>
<td>
Population description pending
</td>
<td>
Intervention description pending
</td>
<td>
Comparison description pending
</td>
<td>
Outcomes description pending
</td>
</tr>
<tr>
<td>
Wu, 2014<br>JAMA Pediatr<br> PMID: <a href="http://pubmed.gov/24862623" target="_blank">24862623</a><br><br><br><br><br><br>
</td>
<td>
447 children in EDs of two tertiary children’s hospitals in U.S.A.<br>• Mean age of 6.5 months<br>• 64.5% boys<br>
</td>
<td>
4 mL of 3% NaCl inhaled<br>• Up to three times in the ED<br>• If admitted, every 8 hrs. <br>All treatments included albuterol sulfate.
</td>
<td>
4 mL of 0.9% NaCl inhaled<br>• Up to three times in the ED<br>• If admitted, every 8 hrs. <br>All treatments included albuterol sulfate.
</td>
<td>
• Hospital admission<br>• <a href="http://www.wikidoc.org/index.php/Respiratory_distress_assessment_instrument" target="_blank">Respiratory Distress Assessment Instrument</a><br>• Length of stay among admitted patients
</td>
</tr>
<tr>
<td>
Florin, 2014<br>JAMA Pediatr<br> PMID: <a href="http://pubmed.gov/24862342" target="_blank">24862342</a>
</td>
<td>
62 children in EDs of a tertiary children’s hospital in U.S.A.<br>• First episode of bronchiolitis<br>• <a href="http://www.wikidoc.org/index.php/Respiratory_distress_assessment_instrument" target="_blank">Respiratory Distress Assessment Instrument</a> of 4 to 15 after albuterol treatment<br>• Mean age of 6.6 months<br>• 45% boys<br>
</td>
<td>
Single inhalation of 4 mL of 3% NaCl using a jet nebulizer with an oxygen flow rate of 8 L/min.
</td>
<td>
Single inhalation of 4 mL of 0.9% NaCl using a jet nebulizer with an oxygen flow rate of 8 L/min.
</td>
<td>
• <a href="http://www.wikidoc.org/index.php/Respiratory_distress_assessment_instrument" target="_blank">Respiratory Distress Assessment Instrument</a> at one hour<br>• Hospital admission
</td>
</tr>
</table>
